World Health Organization

Global Impact launches new $5M research fund - Vaccine Confidence Fund II to further understand how Social Media may be leveraged to Increase Vaccination Confidence and Uptake

Retrieved on: 
Friday, August 5, 2022 - 11:19pm

This round of funding for global research will focus on harnessing the power of social media to increase vaccination confidence and uptake with an emphasis on enhancing routine immunization and educating health care workers on addressing vaccine hesitancy.

Key Points: 
  • This round of funding for global research will focus on harnessing the power of social media to increase vaccination confidence and uptake with an emphasis on enhancing routine immunization and educating health care workers on addressing vaccine hesitancy.
  • Global Impact is publishing the Full Insights Report on the first Vaccine Confidence Fund which features findings from the grantees research and insights on potential ways to drive vaccination confidence and uptake.
  • Through these partnerships, Global Impact has raised nearly $2 billion for causes such as disaster relief and global development.
  • Global Impacts reach and services are complemented by the work of its subsidiary company, Geneva Global .

Hepatitis C Tests Market Research Report 2022: Size, Segments, Share, Trends, Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecasts, 2015-2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, August 5, 2022 - 4:39pm

The model discusses in detail the impact of COVID-19 on Hepatitis C Tests market for the year 2020 and beyond.

Key Points: 
  • The model discusses in detail the impact of COVID-19 on Hepatitis C Tests market for the year 2020 and beyond.
  • Hepatitis C is a viral infection caused by hepatitis C virus (HCV).
  • Hepatitis C virus is a blood borne virus that causes liver disease and can cause acute and chronic hepatitis.
  • The Hepatitis C virus tests includes Hepatitis C Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests, Hepatitis C Nucleic Acid Amplification Tests (NAATs) and Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic Acid Amplification Tests (NAATs).

Monkeypox Response: AHF Calls on DeSantis to Not Fail Florida Again!

Retrieved on: 
Friday, August 5, 2022 - 3:43pm

Given the growing number of new cases of monkeypox across the globe, the World Health Organization recently declared the virus a global health emergency.

Key Points: 
  • Given the growing number of new cases of monkeypox across the globe, the World Health Organization recently declared the virus a global health emergency.
  • In a recent article in the Sun-Sentinel, Florida Surgeon General Joseph Ladapo, stated that he is certain there are many more unknown cases across the state.
  • Earlier this week, the Governor stated that he would not declare a public health emergency over the monkeypox outbreak.
  • In the same article, DeSantis referred to it being nonsense and that politicians that were taking leadership in addressing monkeypox, were trying to scare you about this.

Global Nebulizers Market Report 2022: Covid-19 Resulted in Surge in Demand for Nebulizers and Increased Sector Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 4, 2022 - 3:53pm

The "Global Nebulizers Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Nebulizers Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The nebulizer devices market consists of sales of nebulizers used in respiratory care for patients with respiratory diseases including asthma, cystic fibrosis, and COPD.
  • The market is divided by portability into portable nebulizers and tabletop nebulizers.
  • The current Covid-19 pandemic has resulted in a surge in demand for nebulizers.

Global Empty Capsules Market Report 2022: Increasing Pharmaceutical Applications Driving 7.4% Annual Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 3, 2022 - 2:39pm

The "Empty Capsules Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Empty Capsules Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.
  • Also, the growing geriatric population worldwide increases the demand for various therapy drugs and dietary supplements for better health outcomes.
  • In addition, rapid advancements in capsule delivery technologies are set to supplement the market growth.
  • However, ethical concerns, price fluctuations regarding gelatin materials, and stringent regulations in the pharmaceutical industry are expected to hamper the market growth.

Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002

Retrieved on: 
Wednesday, August 3, 2022 - 2:16am

The primary objective of the China CHAMP and Mini-CHAMP trials is to evaluate the efficacy and safety of NVK002 for the treatment of myopia progression in children and adolescents.

Key Points: 
  • The primary objective of the China CHAMP and Mini-CHAMP trials is to evaluate the efficacy and safety of NVK002 for the treatment of myopia progression in children and adolescents.
  • These early completions of patient recruitment across both trials, gives the company a strong headstart in moving towards its goal to lead the market in launching a myopia progression treatment drug.
  • Following this, a New Drug Application ("NDA") submission to the US Food and Drug Administration (the "FDA") is expected in 2023.
  • Dr. Li Xiaoyi (Benjamin), Chairman of the Board of Directors, Executive Director and CEO of Zhaoke Ophthalmology, said, "The early completion of the patient recruitment of NVK002's Phase III clinical trials marks another huge and exciting milestone for Zhaoke Ophthalmology.

Medexus Schedules First Quarter 2023 Conference Call

Retrieved on: 
Tuesday, August 2, 2022 - 10:00pm

TORONTO and CHICAGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX:MDP) (OTCQX:MEDXF) plans to host a conference call at 8:00am Eastern Time on Tuesday, August9, 2022 to discuss Medexuss results for its first quarter ended June30, 2022.

Key Points: 
  • TORONTO and CHICAGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX:MDP) (OTCQX:MEDXF) plans to host a conference call at 8:00am Eastern Time on Tuesday, August9, 2022 to discuss Medexuss results for its first quarter ended June30, 2022.
  • Medexus expects to file its financial statements and MD&A after markets close on August 8, 2022.
  • To access the replay, please dial the following numbers
    877-481-4010 for Canadian and U.S. callers
    A replay of the webcast will be available on the InvestorsNews& EventsIRCalendar section of Medexuss corporate website until Wednesday, August9, 2023.
  • Medexus is a leader in innovative rare disease treatment solutions with a strong North American commercial platform and a portfolio of proven best-in-class products.

Global Automotive Memory Market Forecast Report 2022: Market is Projected to Reach $14,652.8 Million by 2028 from $2,937.7 Million in 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 2, 2022 - 5:01pm

The "Automotive Memory Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Component, Application and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Automotive Memory Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Component, Application and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The automotive memory market is projected to reach US$ 14,652.8 million by 2028 from US$ 2,937.7 million in 2021.
  • The pandemic has wreaked havoc on various industry verticals regarding business and operational factors, including the worldwide automotive memory market players.
  • For instance, in 2021, Samsung Electronics, a global pioneer in advanced memory technology, announced a broad range of cutting-edge automotive memory solutions for next-generation autonomous electric vehicles.

Peptilogics to Participate in Musculoskeletal Infection Society (MSIS) 32nd Annual Open Scientific Meeting in Pittsburgh

Retrieved on: 
Tuesday, August 2, 2022 - 1:30pm

Peptilogics, a biotech company engineering peptide therapeutics to improve the treatment landscape for patients with life-threatening diseases, will participate in the Musculoskeletal Infection Society (MSIS) 32nd Annual Open Scientific Meeting taking place in Pittsburgh August 5-6.

Key Points: 
  • Peptilogics, a biotech company engineering peptide therapeutics to improve the treatment landscape for patients with life-threatening diseases, will participate in the Musculoskeletal Infection Society (MSIS) 32nd Annual Open Scientific Meeting taking place in Pittsburgh August 5-6.
  • With MSIS taking place in Pittsburgh this year, Peptilogics is hosting an opening night reception Thursday, August 4th.
  • As an orthopedic surgeon, I am thrilled to see and work on desperately needed new treatment options such as Peptilogics PLG0206 in preclinical and clinical development.
  • PLG0206 represents an important alternative to traditional antibiotic treatments that have limited effectiveness in treating these infections.

Global Pediatric Vaccines Market to Reach $62 Billion in 2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 2, 2022 - 11:46am

The "Pediatric Vaccines Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pediatric Vaccines Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Global Pediatric Vaccines Market is expected to reach USD 62 Billion in 2027.
  • In this huge market of vaccines Pediatric Vaccines for Coronavirus account for a significant market share.
  • The global pediatric vaccines market is robust and has successfully reached enormous potential.